Tyco to purchase U.S. Surgical
Tyco International of Hamilton, Bermuda, has signed a definitive agreement to acquire U.S. Surgical of Norwalk, CT, in a deal valued at $3.3 billion. Under the terms of the deal, U.S. Surgical would merge with Tyco's disposable medical products group.
Tyco International of Hamilton, Bermuda, has signed a definitive agreement to acquire U.S. Surgical of Norwalk, CT, in a deal valued at $3.3 billion. Under the terms of the deal, U.S. Surgical would merge with Tyco's disposable medical products group. The acquisition is expected to be accounted for as a pooling of interests and is contingent upon regulatory review and approval by U.S. Surgical shareholders. U.S. Surgical's operations in radiology include its ABBI breast biopsy device. The company acquired ultrasound-guided breast biopsy developer NeoVision last year (SCAN 10/1/97).
Considering Breast- and Lesion-Level Assessments with Mammography AI: What New Research Reveals
June 27th 2025While there was a decline of AUC for mammography AI software from breast-level assessments to lesion-level evaluation, the authors of a new study, involving 1,200 women, found that AI offered over a seven percent higher AUC for lesion-level interpretation in comparison to unassisted expert readers.
SNMMI: Can 18F-Fluciclovine PET/CT Bolster Detection of PCa Recurrence in the Prostate Bed?
June 24th 2025In an ongoing prospective study of patients with biochemical recurrence of PCa and an initial negative PSMA PET/CT, preliminary findings revealed positive 18F-fluciclovine PET/CT scans in over 54 percent of the cohort, according to a recent poster presentation at the SNMMI conference.
